Market Cap (In USD)
142.23 Thousand
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0E-4-2.0E-4
- PE
- -
- EPS
- -
- Beta Value
- 1.288
- ISIN
- CA0076282098
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Benjamin Krantz M.B.A., M.D.
- Employee Count
- -
- Website
- https://www.advancedproteome.com
- Ipo Date
- 2009-07-10
- Details
- Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
More Stocks
-
9247
-
NGELFNGE Capital Limited
NGELF
-
ARGXargenx SE
ARGX
-
SABOOSODSaboo Sodium Chloro Limited
SABOOSOD
-
603536
-
FTU
-
KALOKalo Gold Corp.
KALO
-
ISTLTDIST Limited
ISTLTD